| 摘要 |
<p>A process for the preparation of an intravenously administrable IgG, which is free of an anti-complementary activity, in which a polymer of polyethylenepropylene glycol, in particular Pluronic F-68, is added to a solution of IgG and the insoluble material resulting in this way is separated off, and the IgG obtained in this way.</p> |
